1. The role of maintenance therapy in eosinophilic esophagitis: who, why, and how?

   • Hamish Philpott
   • Evan S. Dellon

   Review 10 October 2017 Pages: 165 - 171

2. Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping

   • Yoichi Kakuta
   • Yoshitaka Kinouchi
   • Tooru Shimosegawa

   Review Open access 30 November 2017 Pages: 172 - 180

   

3. Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods

   • Masato Yoneda
   • Kento Imajo
   • Atsushi Nakajima

   Review Open access 24 November 2017 Pages: 181 - 196

   

4. Esophageal cancer stem cells are suppressed by tranilast, a TRPV2 channel inhibitor

   • Atsushi Shiozaki
   • Michihiro Kudou
   • Eigo Otsuji

   Original Article—Alimentary Tract 07 April 2017 Pages: 197 - 207

   

5. Celiac disease in non-clinical populations of Japan

   • Mai Fukunaga
   • Norihisa Ishimura
   • Yoshikazu Kinoshita

   Original Article—Alimentary Tract 07 April 2017 Pages: 208 - 214

   

6. T-lymphocyte-derived enkephalins reduce T_h1/T_h17 colitis and associated pain in mice

   • Lilian Basso
   • Laure Garnier
   • Gilles Dietrich

   Original Article—Alimentary Tract 19 April 2017 Pages: 215 - 226

   

7. Automated cytological detection of Barrett’s neoplasia with infrared spectroscopy

   • Oliver Old
   • Gavin Lloyd
   • Hugh Barr

   Original Article—Alimentary Tract 13 May 2017 Pages: 227 - 235

   

8. Gastrointestinal endoscopy in patients receiving novel direct oral anticoagulants: results from the prospective Dresden NOAC registry

   • Vera Heublein
   • Sven Pannach
   • Jan Beyer-Westendorf

   Original Article—Alimentary Tract 10 May 2017 Pages: 236 - 246

   

9. Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy

   • Akihiro Matsumoto
   • Shuhei Nishiguchi
   • Eiji Tanaka

   Original Article—Liver, Pancreas, and Biliary Tract 20 June 2017 Pages: 247 - 257

   

10. Response criteria of tolvaptan for the treatment of hepatic edema

    • Yasunari Hiramine
    • Haruki Uojima
    • Kazuhiko Koike

    Original Article—Liver, Pancreas, and Biliary Tract 29 June 2017 Pages: 258 - 268

    

11. Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease

    • Takashi Nakahara
    • Hideyuki Hyogo
    • Kazuaki Chayama

    Original Article—Liver, Pancreas, and Biliary Tract 24 July 2017 Pages: 269 - 280

    

12. Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial

    • Masafumi Ikeda
    • Masatoshi Kudo
    • Miriplatin TACE Study Group

    Original Article—Liver, Pancreas, and Biliary Tract Open access 01 August 2017 Pages: 281 - 290

    

13. Telomere length of gallbladder epithelium is shortened in patients with congenital biliary dilatation: measurement by quantitative fluorescence in situ hybridization

    • Yuto Aoki
    • Junko Aida
    • Toshiyuki Ishiwata

    Original Article—Liver, Pancreas, and Biliary Tract 15 November 2017 Pages: 291 - 301

    

14. Correction to: Telomere length of gallbladder epithelium is shortened in patients with congenital biliary dilatation: measurement by quantitative fluorescence in situ hybridization

    • Yuto Aoki
    • Junko Aida
    • Toshiyuki Ishiwata

    Correction 05 December 2017 Pages: 302 - 303